TABLE 1.
Plasmid | Mutation | IC (μg/ml) |
---|---|---|
pBluescript II SK | 5 | |
pBR322 | 96 | |
pSK4646 | 48 | |
G151 mutations | ||
pSK4591 | G151R | 5 |
pSK4592 | G151V | 10 |
pSK4594 | G151E | 5 |
pSK4595 | G151D | 5 |
pSK4596 | G151L | 5 |
pSK4597 | G151K | 5 |
pSK4598 | G151A | 48 |
pSK4599 | G151S | 48 |
G155 mutations | ||
pSK4400 | G155D | 5 |
pSK4538 | G155A | 48 |
pSK4539 | G155R | 5 |
pSK4541 | G155P | 5 |
pSK4543 | G155S | 48 |
pSK4544 | G155T | 5 |
pSK4549 | P155S-P156S | 32 |
P156 mutations | ||
pSK4551 | P156A | 5 |
pSK4552 | P156R | 5 |
pSK4555 | P156L | 5 |
pSK4556 | P156T | 5 |
pSK4559 | P156V | 5 |
pSK4560 | P156N | 5 |
pSK4561 | P156Q | 5 |
pSK4562 | P156G | 12 |
pSK4563 | P156H | 5 |
pSK4564 | P156I | 5 |
pSK4565 | P156K | 5 |
pSK4566 | P156S | 5 |
G159 mutations | ||
pSK4568 | G159A | 8 |
pSK4570 | G159R | 5 |
pSK4571 | G159D | 5 |
pSK4572 | G159N | 5 |
pSK4573 | G159E | 5 |
pSK4574 | G159P | 5 |
pSK4575 | G159S | 8 |
pSK4576 | G159T | 5 |
pSK4577 | G159V | 8 |
G160 mutations | ||
pSK4579 | G160V | 10 |
pSK4580 | G160T | 5 |
pSK4581 | G160L | 5 |
pSK4582 | G160I | 5 |
pSK4583 | G160E | 5 |
pSK4584 | G160Q | 5 |
pSK4585 | G160R | 5 |
pSK4586 | G160A | 48 |
pSK4588 | G160S | 32 |
All mutants were constructed by site-directed mutagenesis procedures, with the exception of the hydroxylamine-generated G155 mutation of pSK4400 and the second-site suppressor mutation of pSK4541, pSK4549 (see Materials and Methods for details).